| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
285,502,000 as of 6/30 |
| Market
Cap: |
2.00(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.09 - $7.83 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 30.5 |
| Insider 6 Months : 41.4 |
| Insider 3/6 Months : 71.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Opko Health is a pharmaceutical and diagnostics company. Co.'s primary program is a molecular diagnostics platform for the development and commercialization of blood-based tests for conditions such as Alzheimer's disease. Co.'s diagnostic instrument system provides blood test results and enables tests to be run in point-of-care settings. Co.'s product pipeline also includes pharmaceutical compounds and technologies such as its oligonucleotide therapeutics technology, and therapeutic agents for respiratory disorders in clinical development, including products for asthma, chronic obstructive pulmonary disease, and chronic cough. Co. is also developing a protein-based influenza vaccine.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,362,800 |
4,216,300 |
10,979,700 |
20,005,402 |
| Total Buy Value |
$16,671,873 |
$26,101,023 |
$55,799,877 |
$92,991,013 |
| Total People Bought |
4 |
4 |
4 |
7 |
| Total Buy Transactions |
52 |
97 |
209 |
344 |
| Total Shares Sold |
0 |
50,000 |
50,000 |
100,000 |
| Total Sell Value |
$0 |
$336,000 |
$336,000 |
$505,860 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
2 |
| End Date |
2013-02-17 |
2012-11-16 |
2012-05-18 |
2011-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-16 |
4 |
B |
$7.00 |
$414,987 |
I/I |
59,100 |
125,569,844 |
1.5 |
- |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-15 |
4 |
B |
$7.08 |
$94,578 |
I/I |
13,300 |
125,510,744 |
1.5 |
-2% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-14 |
4 |
B |
$6.90 |
$243,339 |
I/I |
35,100 |
125,497,444 |
1.5 |
1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-13 |
4 |
B |
$6.79 |
$321,326 |
I/I |
46,900 |
125,462,344 |
1.5 |
2% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-10 |
4 |
B |
$6.83 |
$72,039 |
I/I |
10,500 |
125,415,444 |
1.5 |
1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-09 |
4 |
B |
$6.72 |
$72,515 |
I/I |
10,700 |
125,404,944 |
1.5 |
3% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-08 |
4 |
B |
$6.66 |
$281,030 |
I/I |
42,000 |
125,394,244 |
1.5 |
5% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-07 |
4 |
B |
$6.72 |
$152,131 |
I/I |
22,500 |
125,352,244 |
1.5 |
4% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-06 |
4 |
B |
$6.64 |
$159,250 |
I/I |
23,800 |
125,329,744 |
1.5 |
5% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-03 |
4 |
B |
$6.67 |
$183,902 |
I/I |
27,500 |
125,305,944 |
1.5 |
5% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-02 |
4 |
B |
$6.51 |
$524,888 |
I/I |
80,000 |
125,278,444 |
1.5 |
7% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-05-01 |
4 |
B |
$6.41 |
$465,953 |
I/I |
72,500 |
125,198,444 |
1.5 |
9% |
|
| Rubin Steven D |
Executive VP-Administration |
• • – |
2013-05-01 |
4 |
B |
$6.45 |
$27,771 |
D/D |
4,300 |
4,195,468 |
2.81 |
9% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-30 |
4 |
B |
$6.64 |
$300,955 |
I/I |
45,000 |
125,125,944 |
1.5 |
5% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-29 |
4 |
B |
$6.83 |
$171,592 |
I/I |
25,000 |
125,080,944 |
1.5 |
2% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-26 |
4 |
B |
$6.90 |
$345,964 |
I/I |
50,000 |
125,055,944 |
1.5 |
1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-24 |
4 |
B |
$6.77 |
$692,447 |
I/I |
100,000 |
125,005,944 |
1.5 |
1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-10 |
4 |
B |
$7.08 |
$141,910 |
I/I |
20,000 |
124,905,944 |
1.5 |
-1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-09 |
4 |
B |
$6.86 |
$1,742,005 |
I/I |
250,600 |
124,885,944 |
1.5 |
1% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-05 |
4 |
B |
$7.15 |
$200,914 |
I/I |
28,000 |
124,635,344 |
1.5 |
-2% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-04 |
4 |
B |
$7.07 |
$158,728 |
I/I |
22,200 |
124,607,344 |
1.5 |
-4% |
|
| Hsiao Jane Ph D |
Vice Chairman & CTO |
• • • |
2013-04-03 |
4 |
B |
$6.99 |
$34,950 |
D/D |
5,000 |
17,905,231 |
3.23 |
0% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-03 |
4 |
B |
$6.75 |
$1,089,197 |
I/I |
156,500 |
124,585,144 |
1.5 |
0% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-02 |
4 |
B |
$7.34 |
$681,642 |
I/I |
91,900 |
124,428,644 |
1.5 |
-5% |
|
| Frost Gamma Investment Trust |
CEO & Chairman |
– – • |
2013-04-01 |
4 |
B |
$7.40 |
$498,607 |
I/I |
66,900 |
124,336,744 |
1.5 |
-7% |
|
806 Records found
|
|
Page 1 of 33 |
|
|
0.12 (1.68%) 
